Organon CEO on Merck spin-off, pandemic impact and more

Kevin Ali, Organon CEO, and CNBC's Meg Tirrell join 'The Exchange to discuss the Merck spin-off, the opportunity he sees in the women's health market and how the company was affected by the pandemic.